NasdaqCM - Delayed Quote USD

Cosmos Health Inc. (COSM)

Compare
0.8701 -0.0451 (-4.93%)
At close: 4:00 PM EDT
0.8773 +0.01 (+0.83%)
After hours: 5:54 PM EDT
Loading Chart for COSM
DELL
  • Previous Close 0.9152
  • Open 0.9000
  • Bid 0.8646 x 100
  • Ask 0.8767 x 100
  • Day's Range 0.8501 - 0.9124
  • 52 Week Range 0.4680 - 1.7000
  • Volume 260,381
  • Avg. Volume 2,450,626
  • Market Cap (intraday) 15.442M
  • Beta (5Y Monthly) 3.13
  • PE Ratio (TTM) --
  • EPS (TTM) -2.2800
  • Earnings Date Nov 18, 2024 - Nov 22, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

www.cosmosholdingsinc.com

123

Full Time Employees

December 31

Fiscal Year Ends

Recent News: COSM

View More

Performance Overview: COSM

Trailing total returns as of 9/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

COSM
38.29%
S&P 500
20.45%

1-Year Return

COSM
49.71%
S&P 500
32.46%

3-Year Return

COSM
81.67%
S&P 500
28.95%

5-Year Return

COSM
72.81%
S&P 500
92.48%

Compare To: COSM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: COSM

View More

Valuation Measures

Annual
As of 9/25/2024
  • Market Cap

    16.24M

  • Enterprise Value

    27.69M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.25

  • Price/Book (mrq)

    0.51

  • Enterprise Value/Revenue

    0.49

  • Enterprise Value/EBITDA

    -1.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -38.19%

  • Return on Assets (ttm)

    -20.23%

  • Return on Equity (ttm)

    -56.61%

  • Revenue (ttm)

    56.45M

  • Net Income Avi to Common (ttm)

    -28.8M

  • Diluted EPS (ttm)

    -2.2800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    365.02k

  • Total Debt/Equity (mrq)

    36.78%

  • Levered Free Cash Flow (ttm)

    -6.86M

Research Analysis: COSM

View More

Company Insights: COSM

Research Reports: COSM

View More

People Also Watch